These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 23016783

  • 1. Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for intervention.
    Guido M, Tinelli A, De Donno A, Bruno AR, Tagliaferro L, Fedele A, Carbone A, Menegazzi P, Aprile V, Greco M, Malvasi A, Piccinni MA, Turano S, Grima P, Dell' Ederam D, Zizza A.
    Curr Pharm Des; 2013; 19(8):1498-507. PubMed ID: 23016783
    [Abstract] [Full Text] [Related]

  • 2. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
    Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G, NTCC Working Group.
    J Clin Virol; 2014 Jul; 60(3):257-63. PubMed ID: 24815381
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
    Castellsagué X, Klaustermeier J, Carrilho C, Albero G, Sacarlal J, Quint W, Kleter B, Lloveras B, Ismail MR, de Sanjosé S, Bosch FX, Alonso P, Menéndez C.
    Int J Cancer; 2008 Apr 15; 122(8):1901-4. PubMed ID: 18076064
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of human papillomavirus genotypes in cervical cancer.
    Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y.
    Int J Gynecol Cancer; 2012 Jul 15; 22(6):1063-8. PubMed ID: 22706225
    [Abstract] [Full Text] [Related]

  • 6. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2007 Mar 23; 56(RR-2):1-24. PubMed ID: 17380109
    [Abstract] [Full Text] [Related]

  • 7. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
    Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, Garland SM, WHINURS group.
    J Clin Virol; 2014 Jul 23; 60(3):250-6. PubMed ID: 24854516
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX, Retrospective International Survey and HPV Time Trends Study Group.
    Lancet Oncol; 2010 Nov 23; 11(11):1048-56. PubMed ID: 20952254
    [Abstract] [Full Text] [Related]

  • 9. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.
    Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX, de Sanjosé S, Spanish study group RIS HPV TT.
    Gynecol Oncol; 2012 Mar 23; 124(3):512-7. PubMed ID: 22119990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M, Quiero A, Vergara N, Espinoza G, Martín HS, Rojas G, Ramírez E.
    Med Microbiol Immunol; 2016 Dec 23; 205(6):585-594. PubMed ID: 27539577
    [Abstract] [Full Text] [Related]

  • 12. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
    Muñoz N, Manalastas R, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A.
    Lancet; 2009 Jun 06; 373(9679):1949-57. PubMed ID: 19493565
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J, Zerat L, Syrjänen K, Zerat JC, Smith JS, Halfon P.
    Vaccine; 2012 Jul 27; 30(35):5215-21. PubMed ID: 22713720
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, Pawlita M.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul 27; 17(7):1731-8. PubMed ID: 18628425
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.
    Dunne EF, Klein NP, Naleway AL, Baxter R, Weinmann S, Riedlinger K, Fetterman B, Steinau M, Scarbrough MZ, Gee J, Markowitz LE, Unger ER.
    Cancer Causes Control; 2013 Feb 27; 24(2):403-7. PubMed ID: 23292130
    [Abstract] [Full Text] [Related]

  • 16. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
    Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Joura EA, Kurman RJ, Majewski S, Muñoz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan J, Lupinacci LC, Giacoletti KE, Sings HL, James M, Hesley TM, Barr E.
    J Infect Dis; 2009 Apr 01; 199(7):926-35. PubMed ID: 19236279
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.
    Vaccine; 2013 Dec 31; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [Abstract] [Full Text] [Related]

  • 18. Universal Human Papillomavirus Vaccination and its Impact on the Southern Italian Region.
    Guid M, Bruno A, Tagliaferro L, Aprile V, Tinelli A, Fedele A, Lobreglio G, Menegazzi P, Pasanisi G, Tassi V, Forcina B, Fortunato F, Lupo LI, Zizza A.
    Curr Pharm Des; 2020 Dec 31; 26(3):343-357. PubMed ID: 32048956
    [Abstract] [Full Text] [Related]

  • 19. Human papilloma virus (HPV) genotypes prevalence in a region of South Italy (Apulia).
    Coscia MF, Monno R, Ballini A, Mirgaldi R, Dipalma G, Pettini F, Cristallo V, Inchingolo F, Foti C, de Vito D.
    Ann Ist Super Sanita; 2015 Dec 31; 51(3):248-51. PubMed ID: 26428051
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I, Tondeur L, Arowas L, Demazoin M, Falguières M, Parent Du Chatelet I, pour le groupe CHlaHPV.
    J Infect Dis; 2017 Mar 01; 215(5):757-763. PubMed ID: 28011911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.